TP53 and neoplasm: In this study, we initially analysed the relationship between the NEDI and molecular and clinical features and found a strong association between the NEDI and LUAD.2, one of the molecular subtypes of LUAD previously defined by TCGA and known to exhibit higher tumour ploidy and mutation rates and to frequently harbour TP53 mutations [50].